Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BI 34021 - Healthy
    Clinical Study Number 1258.1
    Study Indication Healthy
    Product BI 34021
    Generic Name BI 34021
    Lab Code
    Clinical Phase I
    Study Title

    Safety, tolerability and pharmacokinetics of BI 34021 FU2 oral drinking solution in healthy male volunteers (dose range: 5 - 500 mg). A double-blind (within dose groups), randomised, placebo-controlled within dose groups,single-rising dose study, including re-dosing at 50 mg and 150 mg (food effect) and at 100 mg (two 50 mg tablets)

    Study Document
    Trial synopsis 1258.1 english